1. Home
  2. RYTM vs AN Comparison

RYTM vs AN Comparison

Compare RYTM & AN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$93.66

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo AutoNation Inc.

AN

AutoNation Inc.

HOLD

Current Price

$185.67

Market Cap

6.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
AN
Founded
2008
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.4B
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
RYTM
AN
Price
$93.66
$185.67
Analyst Decision
Strong Buy
Buy
Analyst Count
14
9
Target Price
$131.14
$244.33
AVG Volume (30 Days)
555.5K
313.9K
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
28.34
0.71
EPS
N/A
5.85
Revenue
N/A
$27,631,400,000.00
Revenue This Year
$55.34
$4.32
Revenue Next Year
$86.06
$2.89
P/E Ratio
N/A
$33.48
Revenue Growth
N/A
3.24
52 Week Low
$60.99
$176.62
52 Week High
$122.20
$228.92

Technical Indicators

Market Signals
Indicator
RYTM
AN
Relative Strength Index (RSI) 62.82 42.44
Support Level $82.43 $178.45
Resistance Level $100.69 $215.56
Average True Range (ATR) 4.46 5.40
MACD 0.64 0.42
Stochastic Oscillator 81.49 4.75

Price Performance

Historical Comparison
RYTM
AN

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About AN AutoNation Inc.

AutoNation is the second-largest automotive dealer in the United States, with 2025 revenue of $27.6 billion and over 240 dealerships, plus 52 collision centers. The firm also has 26 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which has proved to be a smart move.

Share on Social Networks: